Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-08

Clinical Trial Update: Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intravenous ketamine for pain control during first-trimester surgical abortion has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Dr. Marie Eve Sophie Bussiere-Cote | Conditions: Abortion in First Trimester | Phase 3 | Status: SUSPENDED